Cardiovascular diseases (CVDs) are the leading cause of mortality post-transplant, driven by prevalent traditional risk factors, along with complications related to chronic kidney disease (CKD), such as left ventricular hypertrophy and mineral bone disease, which often persist after the transplant [3, 4]
Marked dose-dependent effects on body weight and nitrogen retention were produced, with the highest IGF-I dose, 695 micrograms/day, giving a 6 g increase in body weight over 7 days, compared with a 19 g loss in the dexamethasone-only group and an 18 g gain in pair-fed controls
The peptide's modified structure allows it to bypass typical protein binding that would normally limit its effectiveness
Metformin increases insulin sensitivity Metformin helps make you more insulin-sensitive by activating AMP-activated protein kinase (AMPK)
BMI Between 30 and 35 Requires associated conditions such as uncontrolled hypertension or advanced stage chronic kidney disease